Gene Copy Mapping of the ERBB2/TOP2A Region in Breast Cancer

Genes Chromosomes and Cancer

Volumn 40, Issue 1, 2004, Pages 19-31

  Jacobson, Kris K ^a   Morrison, Larry E ^a   Henderson, Benita T ^a   Blondin, Beth A ^a   Wilber, Kimberly A ^a   Legator, Mona S ^a   O'Hare, Anna ^a   Van Stedum, Susan C ^a   Proffitt, John H ^a   Seelig, Steve A ^a   Coon, John S ^b  

^a ABBOTT LABORATORIES   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CHROMOSOME 17Q; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL; TOP2A GENE;

ANAPHASE; ANTIGENS, NEOPLASM; BREAST NEOPLASMS; CENTROMERE; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA PROBES; DNA TOPOISOMERASES, TYPE II, EUKARYOTIC; DNA, NEOPLASM; DNA-BINDING PROTEINS; GENE AMPLIFICATION; GENE DOSAGE; GENES, ERBB-2; HUMANS; MODELS, GENETIC; ONCOGENE PROTEINS, FUSION; PARAFFIN EMBEDDING; RECEPTOR, ERBB-2; RECOMBINATION, GENETIC;

EID: 11144353704     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20019     Document Type: Article

References (24)

1. Brodeur GM. 1998. Gene amplification in human cancers: biological and clinical significance. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill. p 161-172.
2. Cook JG, Park CH, Burke TW, Leone G, DeGregori J, Engel A, Nevins JR. 2002. Analysis of CDC6 function in the assembly of mammalian prereplication complexes. Proc Natl Acad Sci USA 99:1347-1352.
3. Coon JS, Marcus E, Gupta-Burt S, Seelig S, Jacobson K, Chen S, Renta V, Fronda G, Preisler HD. 2002. Amplification and over-expression of topoisomerase II alpha predict response to anthracycline-based therapy in locally advanced breast cancer. Clin Cancer Res 8:1061-1067.
4. Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M. 1997. Expression of fragile sites triggers intrachromosomal mammalian gene amplification and sets boundaries to early amplicons. Cell 89:215-225.
5. Di Leo A, Gancberg D, Larsimont D, Tanner M, Jarvinen T, Rouas G, Dolci S, Leroy J, Paesmans M, Isola J, Piccart M. 2002. HER-2 amplification and topoisomerase II alpha gene aberrations as predictive markers in node-positive breast cancer patients randomly treated either with an anthracycline-based therapy or with cyclophosphamide, methotrexate, and 5-fluorouracil. Clin Cancer Res 8:1107-1116.
6. Han DC, Shen TL, Guan JL. 2001. The Grb7 family proteins: structure, interactions with other signaling molecules and potential cellular functions. Oncogene 20:6315-6321.
7. Hosokawa Y, Maeda Y, Takahashi E, Suzuki M, Seto M. 1999. Human aiolos, an ikaros-related zinc finger DNA binding protein: cDNA cloning, tissue expression pattern, and chromosomal mapping. Genomics 61:326-329.
8. Jacobson K, Thompson A, Browne G, Shasserre C, Seelig SA, King W. 2000. Automation of fluorescence in situ hybridization pretreatment: a comparative study of different sample types. Mol Diagn 5:209-220.
9. Jarvinen TA, Tanner M, Barlund M, Borg A, Isola J. 1999. Characterization of topoisomerase II alpha gene amplification and deletion in breast cancer. Genes Chromosomes Cancer 26:142-150.
10. Jarvinen TA, Tanner M, Rantanen V, Barlund M, Borg A, Grenman S, Isola J. 2000. Amplification and deletion of topoisomerase II alpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer. Am J Pathol 156:839-847.
11. Kauraniemi P, Barlund M, Monni O, Kallioniemi A. 2001. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61:8235-8240.
12. Klapper LN, Kirschbaum MH, Sela M, Yarden Y. 2000. Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors. Adv Cancer Res 77:25-79.
13. Melnick A, Licht JD. 1999. Deconstructing a disease: RAR alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 93:3167-3215.
14. Moog-Lutz C, Tomasetto C, Regnier CH, Wendling C, Lutz Y, Muller D, Chenard MP, Basset P, Rio MC. 1997. MLN64 exhibits homology with the steroidogenic acute regulatory protein (STAR) and is over-expressed in human breast carcinomas. Int J Cancer 71:183-191.
15. Muller A, Homey B, Soto H, Ge N, Catron D, Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL, Mohar A, Verastegui E, Zlotnik A. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-56.
16. Pauletti G, Slamon DJ. 1999. Interphase cytogenetics of the HER-2/neu oncogene in breast cancer. In: Andreeff M, Pinkel D, editors. Introduction to fluorescence in situ hybridization, principles and clinical applications. New York: Wiley-Liss. p 153-171
17. Pauletti G, Godolphin W, Press MF, Slamon DJ. 1996. Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization. Oncogene 13:63-72.
18. Pauletti G, Dandekar S, Rong H, Ramos L, Peng H, Seshadri R, Slamon DJ. 2000. Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry. J Clin Oncol 18:3651-3664.
19. Persons DL, Bui MM, Lowery MC, Mark HF, Yung JF, Birkmeier JM, Wong EY, Yang SJ, Masood S. 2000. Fluorescence in situ hybridization (FISH) for detection of HER-2/neu amplification in breast cancer: a multicenter portability study. Ann Clin Lab Sci 30:41-48.
20. Pipiras E, Coquelle A, Bieth A, Debatisse M. 1998. Interstitial deletions and intrachromosomal amplification initiated from a double-strand break targeted to a mammalian chromosome. Embo J 17:325-333.
21. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177-182.
22. Takanashi M, Yagi T, Imamura T, Tabata Y, Morimoto A, Hibi S, Ishii E, Imashuku S. 2002. Expression of the Ikaros gene family in childhood acute lymphoblastic leukaemia. Br J Haematol 117: 525-530.
23. van de Vijver MJ. 2001. Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2). Eur J Cancer 37(Suppl 1):11-17.
24. Wang W, Chi T, Xue Y, Zhou S, Kuo A, Crabtree GR. 1998. Architectural DNA binding by a high-mobility-group/kinesin-like subunit in mammalian SWI/SNF-related complexes. Proc Natl Acad Sci USA 95:492-498.